,
Stranix-Chibanda, L. http://orcid.org/0000-0003-3566-1688
Brummel, S.
Pilotto, J.
Mutambanengwe, M.
Chanaiwa, V.
Mhembere, T.
Kamateeka, M.
Aizire, J.
Masheto, G.
Chamanga, R.
Maluwa, M.
Hanley, S.
Joao, E.
Theron, G.
Nevrekar, N.
Nyati, M.
Santos, B.
Aurpibul, L.
Mubiana-Mbewe, M.
Oliveira, R.
Anekthananon, T.
Mlay, P.
Angelidou, K.
Tierney, C.
Ziemba, L.
Coletti, A.
McCarthy, K.
Basar, M.
Chakhtoura, N.
Browning, R.
Currier, J.
Fowler, M. G.
Flynn, P.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases of the National Institutes of Health (UM1AI068632, UM1AI068616, UM1AI106716)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Article History
First Online: 9 August 2019
Compliance with Ethical Standards
:
: Dr. Flynn is a consultant for Merck. Dr Stranix-Chibanda, Dr Fowler and rest of co-authors declare no conflict of interest.
: The PROMISE studies have been approved by the appropriate institutional and/or national research ethics committees in all research sites and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.